Privia Health Group Inc.
PRVA | NASDAQ
$19.54
-$0.31 (-1.56%)
At close: Sep 21, 2026, 4:00 PM ET
$19.66
+$0.12 (+0.62%)
Pre-market:
Sep 22, 2026, 5:05 AM ET
Market Data
Market Cap $2.5B
Enterprise Value $-401B
Beta 0.88
Average Volume 1.17M
Shares Outstanding (Diluted) 131.83M
Shares Change YoY 2.63%
Institutional Ownership 97.36%
Exchange NASDAQ
ISIN US74276R1023
Price Performance
Price Change 1M -8.0%
Price Change 3M -17.7%
Price Change 6M -4.9%
Price Change YTD -16.7%
Price Change 1Y -14.7%
Price Change 3Y -9.7%
Price Change 5Y -24.3%
1M CAGR (ann.) -9.8%
1Y CAGR (ann.) -10.6%
5Y CAGR (ann.) -7.6%
All-Time CAGR -2.7%
Valuation
PE Ratio 88.82
Forward PE 46.52
PEG Ratio 1.06
Forward PEG 1.42
PS Ratio 1.04
Forward PS 0.90
PB Ratio 0.00
P/FCF Ratio -51.04
P/Adj. FCF Ratio -0.06
P/OCF Ratio -52.81
EV/Sales -170.06
EV/EBIT -7,147.27
EV/EBITDA -5,882.77
EV/FCF 8,312.18
Earnings Yield 1.1%
FCF Yield -2.0%
Adj. FCF Yield -1680.0%
Financial Health
Net Cash $403.47B
Total Debt $8.73B
Cash & Short-Term Investments $412.2B
Total Assets $1.49T
Current Ratio 1.62
Quick Ratio 1.62
Debt / Equity Ratio 0.01
Debt / EBITDA 128.11
Debt / FCF -181.02
OCF / Debt -0.01
Interest Coverage 0.00
Altman Z-Score 0.18
Piotroski F-Score 1
Margins & Profitability
Gross Profit Margin 7.6%
Operating Profit Margin 1.9%
EBITDA Margin 2.9%
Net Profit Margin 1.2%
FCF Margin -2.0%
Adj. FCF Margin -1754.2%
SBC / Revenue 1752.2%
SBC Impact (per share) -85643.5%
Returns
Return on Assets 0.0%
Return on Equity 0.0%
Return on Invested Capital 0.0%
Return on Capital Employed 0.0%
Return on Tangible Assets 0.0%
Historical Growth (CAGR)
Revenue CAGR 3Y 16.1%
Revenue CAGR 5Y 22.4%
Revenue CAGR 10Y N/A
EPS CAGR 3Y -5.4%
EPS CAGR 5Y 234.6%
EPS CAGR 10Y N/A
FCF CAGR 3Y -155.5%
FCF CAGR 5Y -33.9%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Buy
Analyst Count 22
EPS Growth Next 3Y 49.8%
Revenue Growth Next 3Y 10.3%
Earnings Date Nov 4, 2026
EPS Estimate (next Q) $0.09
EPS Growth Est (next Q) 80.0%
Revenue Est (next Q) $610.63M
Revenue Growth Est (next Q) 5.2%
Fair Value Estimates
Graham Number $181.36
Graham Upside 828.1%
Lynch Fair Value $5.50
Lynch Upside -71.8%
Price Target $27.33
Price Target Upside 39.9%
Cash Flow
Operating Cash Flow $-47.04M
Free Cash Flow $-48.24M
Adj. Free Cash Flow $-41.37B
FCF Per Share -$0.38
OCF Per Share -$0.37
OCF/S Ratio -2.0%
Income Statement
Revenue $2.36B
Gross Profit $179.46M
Operating Income $44.88M
EBITDA $68.17M
Net Income $28.12M
EPS (Diluted) $0.22
Revenue / Employee $1.92M
Profit / Employee $22.94K
Employees 1,226
Add to Watchlist
Select watchlists to add or remove PRVA